These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 21073664)

  • 41. [Latent autoimmune (Type-1) diabetes mellitus in adults. Part. I. Serologic markers of autoimmune involvement of pancreatic beta-cells: GADA, ICA, IA-2 a IA-A].
    Martinka E; Ocenásová A; Straková J; Mokán M
    Vnitr Lek; 1999 Feb; 45(2):97-102. PubMed ID: 15641228
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The natural history of type 1A diabetes.
    Eisenbarth GS; Jeffrey J
    Arq Bras Endocrinol Metabol; 2008 Mar; 52(2):146-55. PubMed ID: 18438525
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Zinc transporter 8 autoantibodies increase the predictive value of islet autoantibodies for function loss of technically successful solitary pancreas transplant.
    Occhipinti M; Lampasona V; Vistoli F; Bazzigaluppi E; Scavini M; Boggi U; Marchetti P; Bosi E
    Transplantation; 2011 Sep; 92(6):674-7. PubMed ID: 21792090
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Development of a luciferase-based system for the detection of ZnT8 autoantibodies.
    Ustinova J; Zusinaite E; Utt M; Metsküla K; Reimand K; Huchaiah V; Merits A; Uibo R
    J Immunol Methods; 2014 Mar; 405():67-73. PubMed ID: 24462542
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Vaccine for prevention of type 1 diabetes mellitus].
    Surković I; Suljević I; Ascić-Buturović B; Heljić B
    Med Arh; 2006; 60(3):198-9. PubMed ID: 16719238
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prognostic Classification Factors Associated With Development of Multiple Autoantibodies, Dysglycemia, and Type 1 Diabetes-A Recursive Partitioning Analysis.
    Xu P; Krischer JP;
    Diabetes Care; 2016 Jun; 39(6):1036-44. PubMed ID: 27208341
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Role of immune system in type 1 diabetes mellitus pathogenesis.
    Szablewski L
    Int Immunopharmacol; 2014 Sep; 22(1):182-91. PubMed ID: 24993340
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Autoantibody tests--an important tool in the diagnosis of type 1 diabetes].
    Kinderkrankenschwester; 2009 Jul; 28(7):296. PubMed ID: 19731761
    [No Abstract]   [Full Text] [Related]  

  • 49. [Zinc transporter 8 (ZnT8) antibody].
    Kawasaki E
    Nihon Rinsho; 2010 Jul; 68 Suppl 7():590-3. PubMed ID: 20960835
    [No Abstract]   [Full Text] [Related]  

  • 50. Organ-specific autoimmunity in relation to clinical characteristics in children with long-lasting type 1 diabetes.
    Głowińska-Olszewska B; Michalak J; Łuczyński W; Del Pilar Larosa M; Chen S; Furmaniak J; Smith BR; Bossowski A
    J Pediatr Endocrinol Metab; 2016 Jun; 29(6):647-56. PubMed ID: 27008690
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Multicenter randomized trial on prevention of type 1 diabetes].
    Kobayashi T
    Nihon Rinsho; 2002 Sep; 60 Suppl 9():48-51. PubMed ID: 12386978
    [No Abstract]   [Full Text] [Related]  

  • 52. Zinc transporter 8 antibodies complement GAD and IA-2 antibodies in the identification and characterization of adult-onset autoimmune diabetes: Non Insulin Requiring Autoimmune Diabetes (NIRAD) 4.
    Lampasona V; Petrone A; Tiberti C; Capizzi M; Spoletini M; di Pietro S; Songini M; Bonicchio S; Giorgino F; Bonifacio E; Bosi E; Buzzetti R;
    Diabetes Care; 2010 Jan; 33(1):104-8. PubMed ID: 19808923
    [TBL] [Abstract][Full Text] [Related]  

  • 53. ZnT8 antibodies in patients with cystic fibrosis: an expression of secondary beta-cell damage?
    Bizzarri C; Giannone G; Benevento D; Montemitro E; Alghisi F; Cappa M; Lucidi V
    J Cyst Fibros; 2013 Dec; 12(6):803-5. PubMed ID: 23535193
    [TBL] [Abstract][Full Text] [Related]  

  • 54. ZnT8 and type 1 diabetes.
    Kawasaki E
    Endocr J; 2012; 59(7):531-7. PubMed ID: 22447136
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Survey of recent clinical trials of the prevention and immunointervention of type 1 diabetes mellitus].
    Boerschmann H; Walter M; Achenbach P; Ziegler AG
    Dtsch Med Wochenschr; 2010 Feb; 135(8):350-4. PubMed ID: 20166000
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Immunogenetics of type 1 diabetes mellitus.
    Morran MP; Vonberg A; Khadra A; Pietropaolo M
    Mol Aspects Med; 2015 Apr; 42():42-60. PubMed ID: 25579746
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Detection of Islet Cell Immune Reactivity with Low Glycemic Index Foods: Is This a Concern for Type 1 Diabetes?
    Kharrazian D; Herbert M; Vojdani A
    J Diabetes Res; 2017; 2017():4124967. PubMed ID: 28819632
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Insulin autoimmunity: prediction/precipitation/prevention type 1A diabetes.
    Eisenbarth GS; Moriyama H; Robles DT; Liu E; Yu L; Babu S; Redondo MJ; Gottlieb P; Wegmann D; Rewers M
    Autoimmun Rev; 2002 May; 1(3):139-45. PubMed ID: 12849007
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Clinical significance of islet-cell antibodies (ICA) for prevention of type 1 diabetes].
    Kobayashi T
    Nihon Rinsho; 2002 Sep; 60 Suppl 9():25-9. PubMed ID: 12386974
    [No Abstract]   [Full Text] [Related]  

  • 60. Clinical utility of measuring both glutamic acid decarboxylase antibodies and islet cell antibodies in the diagnosis of latent autoimmune diabetes in adults - is it cost-effective?
    Hughes LE; Ford C; Ekbote A; Gama R
    Ann Clin Biochem; 2017 Sep; 54(5):623-624. PubMed ID: 28490183
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.